Robert . E. Richard's most recent trade in Lyra Therapeutics Inc was a trade of 45,000 Stock Option done . Disclosure was reported to the exchange on Jan. 31, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lyra Therapeutics Inc | Robert E. Richard | SVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 45,000 | 45,000 | - | - | Stock Option | |
| Lyra Therapeutics Inc | Robert E. Richard | SVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 30,000 | 30,000 | - | 0 | Common Stock | |
| Lyra Therapeutics Inc | Robert E. Richard | SVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2022 | 35,000 | 35,000 | - | - | Stock Option | |
| Lyra Therapeutics Inc | Robert E. Richard | SVP of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 18,000 | 18,000 | - | - | Stock Option |